Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumAndréa Lessa Benedet, Natàlia Vilor‐Tejedor, Alyssa Stevensson et al.|JAMA Neurology|2021Cited by 627
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detectedMarc Suárez‐Calvet, Natàlia Vilor‐Tejedor, Thomas K. Karikari et al.|EMBO Molecular Medicine|2020Cited by 411
Multitracer model for staging cortical amyloid deposition using PET imagingLyduine E. Collij, María Pascual, Fiona Heeman et al.|Neurology|2020Cited by 101
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuumNatàlia Vilor‐Tejedor, Marc Vilanova, Iacopo Ciampa et al.|Alzheimer s Research & Therapy|2021Cited by 68